Article: article from journal or magazin.
Infrequent expression of the MAGE gene family in uveal melanomas.
International journal of cancer. Journal international du cancer
Publication types: Journal Article ; Research Support, Non-U.S. Gov't - Publication Status: ppublish
It has previously been reported that MAGE-1, -2, -3 and -4 genes are expressed in human cancers including cutaneous melanoma. MAGE-1 and MAGE-3 represent targets for specific immunotherapy because they encode peptide antigens which are recognised by cytotoxic T lymphocytes (CTL) when presented by HLA class I molecules, and pilot clinical trials with these peptides are currently in progress. It is likely that other members of the MAGE gene family may also encode antigens recognised by CTL. Uveal melanomas, like cutaneous melanomas, arise from melanocytes that are derived from the neural crest. To determine if uveal melanoma patients would be suitable for MAGE-peptide immunotherapy, the expression of MAGE-1, -2, -3 and -4 genes was assessed by reverse transcription followed by polymerase chain reaction (RT-PCR) amplification and ethidium bromide staining. Expression of MAGE genes was not detected in any of 27 primary tumours. Either MAGE-1 or MAGE-4 was expressed in only 2 of 26 metastatic samples, but expression of MAGE-2 or -3 was not detected. Our data suggest that, unlike cutaneous melanomas, uveal melanomas may not be suitable candidates for MAGE-peptide immunotherapy.
Antigens, Neoplasm, Base Sequence, Gene Expression Regulation, Neoplastic, Humans, Melanoma, Molecular Sequence Data, Multigene Family, Neoplasm Metastasis, Neoplasm Proteins, Polymerase Chain Reaction, RNA, Messenger, RNA, Neoplasm, Uveal Neoplasms
Web of science
Last modification date